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Multilayered regulation of TORC1-body 
formation in budding yeast
ABSTRACT The target of rapamycin kinase complex 1 (TORC1) regulates cell growth and 
metabolism in eukaryotes. In Saccharomyces cerevisiae, TORC1 activity is known to be con-
trolled by the conserved GTPases, Gtr1/2, and movement into and out of an inactive agglom-
erate/body. However, it is unclear whether/how these regulatory steps are coupled. Here we 
show that active Gtr1/2 is a potent inhibitor of TORC1-body formation, but cells missing 
Gtr1/2 still form TORC1-bodies in a glucose/nitrogen starvation-dependent manner. We also 
identify 13 new activators of TORC1-body formation and show that seven of these proteins 
regulate the Gtr1/2-dependent repression of TORC1-body formation, while the remaining 
proteins drive the subsequent steps in TORC1 agglomeration. Finally, we show that the con-
served phosphatidylinositol-3-phosphate (PI(3)P) binding protein, Pib2, forms a complex with 
TORC1 and overrides the Gtr1/2-dependent repression of TORC1-body formation during 
starvation. These data provide a unified, systems-level model of TORC1 regulation in yeast.
INTRODUCTION
The target of rapamycin kinase complex I (TORC1) is a key regulator 
of cell growth and metabolism in eukaryotes (Loewith and Hall, 
2011; Gonzalez and Hall, 2017; Saxton and Sabatini, 2017). In the 
presence of progrowth hormones and ample nutrients, TORC1 is 
active and drives protein, lipid, and nucleotide synthesis by phos-
phorylating a wide range of proteins (Bodenmiller et al., 2010; Hsu 
et al., 2011; Loewith and Hall, 2011; Robitaille et al., 2013; Gonzalez 
and Hall, 2017; Saxton and Sabatini, 2017). In contrast, when 
hormone, nutrient, or energy levels fall—or cells are exposed to 
noxious stress—TORC1 is inhibited, causing the cell to switch from 
anabolic to catabolic metabolism and eventually enter a quiescent 
state (Barbet et al., 1996; Noda and Ohsumi, 1998; Duvel et al., 
2010; Loewith and Hall, 2011; Gonzalez and Hall, 2017; Saxton and 
Sabatini, 2017).
TORC1 is made up of three essential proteins: mTOR, Raptor, 
and mLst8 in humans, and Tor1, Kog1, and Lst8 in yeast (Kim et al., 
2002; Loewith et al., 2002). Biochemical and structural studies show 
that these proteins form a stable, ring-like structure containing two 
copies of each subunit (Adami et al., 2007; Yip et al., 2010; Aylett 
et al., 2016; Yang et al., 2017). Kog1/Raptor recruits substrates to 
the TOR kinase (Tor1) and is required for the regulation of Tor1 activ-
ity (Hara et al., 2002; Kim et al., 2002; Aylett et al., 2016). Lst8, 
however, binds directly to Tor1 and may help stabilize the TOR com-
plex (Kim et al., 2002). In yeast, TORC1 also includes the nonessen-
tial and poorly characterized subunit Tco89 (Reinke et al., 2004).
TORC1 activity is controlled by a variety of proteins and path-
ways (Loewith and Hall, 2011; Gonzalez and Hall, 2017; Nicastro 
et al., 2017; Saxton and Sabatini, 2017), but in the model organism 
Saccharomyces cerevisiae, two major modes of regulation have 
been identified.
First, nitrogen and amino acid signals are transmitted to TORC1 
via a pair of small GTPases called Gtr1 and Gtr2 (Rag A/B and Rag 
C/D in humans) (Kim et al., 2008; Sancak et al., 2008; Binda et al., 
2009). Gtr1 and 2 form a heterodimer that is tethered to the vacu-
olar/lysosomal membrane by a palmitoylated and myristoylated 
complex made up of Ego1, Ego2, and Ego3 (EGO-TC or Ragulator 
in humans) (Roth et al., 2006; Binda et al., 2009; Nadolski and Linder, 
2009; Sancak et al., 2010; Powis et al., 2015). In the presence of 
abundant nitrogen/amino acids, Gtr1 and 2 are in their GTP and 
GDP bound forms, respectively, and bind tightly to Kog1/Raptor 
and Tco89 (Gao and Kaiser, 2006; Sancak et al., 2008; Binda et al., 
2009). In contrast, when nitrogen/amino acid levels fall, Npr2, Npr3, 
and Iml1 (SEACIT in yeast and GATOR1 in humans) bind to Gtr1 and 
Monitoring Editor
Kunxin Luo
University of California, 
Berkeley
Received: May 14, 2018
Revised: Nov 8, 2018
Accepted: Nov 20, 2018
This article was published online ahead of print in MBoC in Press (http://www 
.molbiolcell.org/cgi/doi/10.1091/mbc.E18-05-0297) on November 28, 2018.
*Address correspondence to: Andrew P. Capaldi (capaldi@email.arizona.edu).
© 2019 Sullivan et al. This article is distributed by The American Society for Cell 
Biology under license from the author(s). Two months after publication it is 
available to the public under an Attribution–Noncommercial–Share Alike 3.0 
Unported Creative Commons License (http://creativecommons.org/licenses/
by-nc-sa/3.0).
“ASCB®,” “The American Society for Cell Biology®,” and “Molecular Biology of 
the Cell®” are registered trademarks of The American Society for Cell Biology.
Abbreviations used: PI(3)P, phosphatidylinositol-3-phosphate; PKC, protein 
kinase C; TORC1, target of rapamycin complex I.
Arron Sullivan, Ryan L. Wallace, Rachel Wellington, Xiangxia Luo, and Andrew P. Capaldi*
Department of Molecular and Cellular Biology, University of Arizona, Tucson, AZ 85721-0206
Volume 30 February 1, 2019 Regulation of TORC1-body formation | 401 
induce its GTPase activity (Neklesa and Davis, 2009; Bar-Peled et al., 
2013; Panchaud et al., 2013; Su et al., 2017). The resulting switch—
from GTP bound Gtr1, to GDP bound Gtr1—then causes a confor-
mational change that weakens the interaction between Gtr1/2 and 
TORC1 and rapidly inhibits (τ = 1–2 min) TORC1 signaling (Sancak 
et al., 2008; Binda et al., 2009; Hughes Hallett et al., 2014).
TORC1 is also rapidly (τ = 1–2 min) inactivated in glucose starva-
tion conditions, but this transition occurs normally in strains carrying 
mutations that lock Gtr1/2 in their active (GTP and GDP bound) con-
formations (Urban et al., 2007; Hughes Hallett et al., 2014), indicat-
ing either that glucose does not signal through Gtr1/2 (in contrast to 
the Rags) (Efeyan et al., 2013) or that other regulators dominate the 
response.
Second, glucose and nitrogen starvation cause Kog1, Tco89, 
and—as shown in recent studies—Tor1 (Kira et al., 2016; Prouteau 
et al., 2017) to move from their position spread across the vacuolar 
membrane to a single focus on the edge of the vacuole (Hughes 
Hallett et al., 2015). TORC1-body formation is sped-up ∼20-fold by 
Snf1/AMPK-dependent phosphorylation of Kog1 at Ser 491 and 
494, and more than 100-fold by two glutamine-rich prion-like do-
mains in Kog1 (Hughes Hallett et al., 2015). Analysis of strains with 
mutations that limit TORC1-body formation show that the TORC1-
bodies are not required for rapid TORC1 inactivation (in contrast to 
Gtr1/2) but rather increase the threshold for TORC1 activation in 
cells that have been starved for a significant period of time (Hughes 
Hallett et al., 2015). This creates hysteresis in the TORC1 pathway to 
help ensure that cells remain committed to a starvation state until 
they are exposed to optimal conditions.
It is currently unclear, however, whether or how Gtr1/2 and 
Ego1-3 (EGOC) influence TORC1 localization or what signaling pro-
teins/pathways besides Snf1 regulate TORC1-body formation. As a 
result, there is no unified model of TORC1 regulation in yeast.
Here, to address these questions, we examine the influence that 
Gtr1/2, Ego1-3, and 209 additional proteins (including nearly all 
nonessential kinases and phosphatases in yeast) have on TORC1 
agglomeration using fluorescence microscopy. We show that the 
active (GTP bound) form of Gtr1 is a potent inhibitor of TORC1-
body formation, but cells missing Gtr1 and Gtr2 still form TORC1-
bodies in a glucose/nitrogen starvation-dependent manner. We also 
identify 13 new regulators of TORC1-body formation and show that 
they act in two steps: first, the protein kinase C (PKC) pathway, Sit4, 
Gcn2, and Cka1 work together with SEACIT to override the Gtr1/2-
dependent inhibition of TORC1 agglomeration. Then Ypk1, Cmk1, 
Yak1, Sak1 (all stress/starvation signaling proteins) and the intrinsi-
cally disordered TORC1 subunit Tco89, help drive TORC1 into bod-
ies. Finally, we show that the conserved phosphatidylinositol-
3-phosphate (PI(3)P) binding protein, Pib2, forms a complex with 
TORC1 and overrides the Gtr1/2-dependent repression of TORC1-
body formation during starvation.
Taken together, our data provide a comprehensive, network-
level, view of TORC1 regulation and show that starvation signals 
have to be transmitted through Gtr1/2, before Pib2 and other 
stress/starvation signaling proteins can trigger TORC1-body forma-
tion and lock the TORC1 pathway in an inactive state.
RESULTS
EGOC-dependent control of Kog1-body formation
To measure the influence that EGOC has on TORC1-body forma-
tion, we followed the localization of Kog1 tagged with yellow fluo-
rescent protein (Kog1-YFP) in a wild-type strain and a strain missing 
Gtr1/2 (and thus all interactions between EGOC and TORC1). Cells 
were kept in log phase growth for at least 12 h in synthetic medium 
with dextrose (SD medium) and loaded into chamber slides, and 
three-dimensional images were acquired using a fluorescence 
microscope. The cells were then washed with medium missing 
glucose, and additional images were acquired at regular time 
intervals.
The wild-type strain formed bodies in two phases; 8 ± 5% of 
cells had bodies at time zero, and this increased to ∼50% with a 
time constant of ∼10 min and then >90% with a time constant of 
260 ± 100 min (Figure 1, A and B) (Hughes Hallett et al., 2015). In 
contrast, the gtr1Δgtr2Δ strain formed bodies in a single phase: 
32 ± 4% of cells had bodies at time zero, and this increased to 73 ± 
1% of cells with a time constant of 9 ± 2 min (Figure 1, A and B). 
These data show that deleting Gtr1/2 increases the fraction of cells 
containing TORC1-bodies in nutrient-replete conditions (from 8 ± 
5% to 32 ± 4%) and speeds up body formation during starvation. 
Thus, EGOC acts to repress TORC1-body formation, especially in 
nutrient-replete conditions.
Next, to determine whether starvation signals transmitted 
through EGOC control TORC1-body formation, we followed Kog1-
YFP localization in strains carrying mutations that lock Gtr1 in its 
active state (npr2Δ and GTR1Q65L) (Binda et al., 2009; Panchaud 
et al., 2013). These strains had gross defects in TORC1-body for-
mation in both glucose and nitrogen starvation conditions (Figure 
1, A and B, and Supplemental Figure S1), indicating 1) that the ac-
tive form of EGOC—normally found in nutrient-replete conditions—
is a potent inhibitor of TORC1-body formation and 2) that EGOC is 
converted into its inactive form during both glucose and nitrogen 
starvation, and this in turn allows TORC1 to form bodies.
Kog1 and EGOC colocalize during starvation
To learn more about the influence that EGOC has on TORC1-body 
formation, we followed EGOC localization during glucose and nitro-
gen starvation.
Recent studies have shown that EGOC localizes to both the vac-
uolar membrane, and distinct puncta associated with the vacuolar 
membrane, during growth in nutrient-replete (SD) medium (Binda 
et al., 2009; Kira et al., 2014, 2016). Nitrogen starvation then in-
creases the fraction of cells with EGOC puncta, while mutants that 
disrupt EGOC decrease the fraction of cells with EGOC puncta (Kira 
et al., 2016).
To confirm and extend these results, we tagged Gtr1, Ego1, 
Ego2, and Ego3 with YFP and followed their movement in both 
glucose and nitrogen starvation conditions, using the same proce-
dures described above for the Kog1-YFP experiments.
In line with previous results, we found that EGOC localizes to the 
vacuolar membrane in all cells, and to foci located on the vacuolar 
membrane in around 70% of cells, during log phase growth (Figure 
2, A and B). EGOC then moves into foci in an additional 10 and 20% 
of cells during nitrogen and glucose starvation, respectively, but main-
tains vacuolar membrane localization in all cells (Figure 2, A and B).
The finding that EGOC foci are formed during log phase 
growth—before TORC1 moves into bodies—led us to ask whether 
TORC1-bodies assemble at the EGOC foci. To do this, we examined 
the localization of Kog1 labeled with red fluorescent protein (RFP) 
(Kog1-DuDre) in strains carrying Gtr1-YFP and Ego2-YFP in glucose 
starvation conditions. These experiments showed that TORC1 and 
EGOC foci colocalize in the vast majority of cells containing TORC1 
bodies (98% overlap between Ego2 and Kog1 foci (n = 97), and 95% 
overlap between Gtr1 and Kog1 foci (n = 103), in cells containing 
Kog1-foci) (Figure 2D). Thus, TORC1 interacts with the pool of EGOC 
located on the vacuolar membrane in log growth conditions and 
then moves to the pool of EGOC located in foci during starvation.
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FIGURE 1: EGOC regulates TORC1-body formation. (A) Kog1-YFP localization before (log 
growth) and 60 min after glucose starvation in the wild-type strain, and strains missing Gtr1/2 
(gtr1Δgtr2Δ), Npr2 (npr2Δ), or carrying a constitutively active GTR1Q65L allele (Gtr1on). The 
dashed lines show the position of each cell in the bright-field image. (B) Time-course data 
showing the fraction of cells containing Kog1-YFP puncta in the wild-type strain and strains 
missing Npr2, Gtr1, Gtr2, Gtr1/2, Ego1, Ego3, or carrying a constitutively active Gtr1 allele 
(Gtr1on), during glucose starvation (as labeled). Each time point shows the average and SD from 
experiments carried out on three different days, with 75–300 cells per time point per replicate. 
The solid lines show the best fit to a single exponential for the gtr1Δgtr2Δ, ego1Δ, ego3Δ, 
gtr1Δ, and gtr2Δ strains, a double exponential for the wild-type strain, and a straight line for the 
npr2Δ and Gtr1on strains. The broken lines in the bottom panels show the best fit to the 
wild-type data (from the top panel) for comparison.
The role of EGOC foci in TORC1-body formation
The microscopy data described above suggest that EGOC foci act 
as nucleation sites for TORC1-body formation. If this is true, then 
eliminating the EGOC foci should slow down TORC1-body forma-
tion in strains that maintain interactions between Gtr1/2 and TORC1.
To test this prediction, we followed Kog1-YFP localization in 
strains missing Gtr1 alone and Gtr2 alone, since they do not form 
EGOC foci (Figure 2C) (Kira et al., 2016) but may maintain weak in-
teractions between Gtr2 and TORC1 and then Gtr1 and TORC1, 
respectively. These strains form more TORC1-bodies than the wild-
type strain in log growth conditions (indicating that the repression of 
TORC1-body formation by active EGOC requires an intact Gtr1/2 
complex) but then form TORC1-bodies (7–11 times) slower than the 
wild-type strain (Figure 1B; τ = 107 ± 27 and 67 ± 37 min for the 
gtr1Δ and gtr2Δ strains vs. 11 ± 3 min for the wild-type strain).
We then followed Kog1-YFP localization in strains missing Ego1 
alone and Ego3 alone, since they also fail to form EGOC foci (Figure 
2C) but probably maintain some interaction between Gtr1/2 and 
TORC1. These strains form the same num-
ber of TORC1-bodies as the wild-type strain 
in log growth conditions (indicating that 
Gtr1/2 represses TORC1-body formation 
efficiently even when it is not tethered to 
the vacuolar membrane), and then—as pre-
dicted—form bodies (6–10 times) slower 
than the wild-type strain (Figure 1B; τ = 58 ± 
19 and 99 ± 52 min for ego1Δ and ego3Δ 
strains vs. 11 ± 3 min for the wild-type strain).
Thus, while the main role of EGOC is to 
repress TORC1-body formation during log 
phase growth, it appears that interactions 
between TORC1 and the EGOC in foci (or 
TORC1 and other proteins in the EGOC 
foci) helps speed up TORC1-body forma-
tion during starvation (see the Supplemental 
Text and Supplemental Figure S2 for further 
discussion).
Activators of TORC1-body formation
To identify additional regulators of TORC1-
body formation, we measured Kog1-YFP 
localization in 209 strains—each missing 
one of 139 nonessential kinases/phospha-
tases in yeast (Breitkreutz et al., 2010) or one 
of 70 genes of interest—many of which were 
found to interact with the TORC1 pathway 
in a previous screen (Worley et al., 2015). 
Cells were kept in log phase growth for at 
least 12 h and transferred into glucose-free 
medium for 60 min, and then three-dimen-
sional images were acquired using a fluores-
cence microscope. Most of the strains 
formed more TORC1-bodies than the wild-
type parental strain during starvation, but 
there were 40 outliers—all with significant 
(greater than twofold) defects in TORC1-
body formation (Figure 3A). To follow this 
up, we grew the 45 strains that formed the 
fewest bodies in the screen (green bar, 
Figure 3A), and the 13 strains that formed 
the largest number of bodies in the screen 
(red bar, Figure 3A), and measured Kog1-
YFP localization as a function of time in both glucose and nitrogen 
starvation conditions (Figure 3B). These experiments confirmed the 
findings from the initial screen and led to the identification of 13 
strains that have dramatic defects in TORC1-body formation (<10% 
of cells with bodies after 2 h of glucose starvation vs. 78% of cells 
with bodies in the wild-type strain), namely pib2Δ, rom2Δ, tco89Δ, 
sit4Δ, yak1Δ, ypk1Δ, bck1Δ, sak1Δ, gcn2Δ, cmk1Δ, ypl150wΔ, 
cka1Δ, and slt2Δ (Figure 3, B and C). The defect in the pib2Δ strain 
was especially pronounced (blue line, Figure 3C), and in subsequent 
experiments we found that <5% of pib2Δ cells form TORC1-bodies 
after 24 h of starvation (vs. >90% in the wild-type strain).
To determine whether the genes that regulate TORC1-body for-
mation also control the rapid inactivation of TORC1, we measured 
TORC1 activity during glucose starvation in 14 different strains—
each missing one gene that is important for TORC1-body formation 
(including all 13 genes listed above). To do this, we followed the 
phosphorylation of the key TORC1 substrate, Sch9, during glucose 
starvation (Urban et al., 2007; Hughes Hallett et al., 2014). These 
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FIGURE 2: EGOC forms puncta in log growth and starvation conditions. (A) Gtr1-YFP and Ego1-YFP localization before 
(log growth), and 60 min after, glucose and nitrogen starvation. The dashed lines show the position of each cell in the 
bright-field image. (B) Time-course data showing the fraction of cells containing Ego1-YFP, Ego2-YFP, Ego3-YFP, and 
Gtr1-YFP puncta during glucose and nitrogen starvation (top and bottom panels, respectively). (C) Time-course data 
showing the fraction of cells containing Gtr1-YFP, Ego1-YFP, and Ego2-YFP puncta in strains missing Gtr1, Gtr2, Ego1, 
or Ego3 (as labeled). For B and C, each time point shows the average and SD from experiments carried out on two 
different days, with 100–300 cells per time point per replicate. (D) Localization of Gtr1-YFP and Kog1-DuDre (top panel) 
and Ego2-YFP and Kog1-DuDre (bottom panel) after 60 min of glucose starvation.
experiments showed that TORC1 was repressed as normal (or 
somewhat overrepressed) in 12 of these strains (Figure 3D and 
Supplemental Figure S3), and while the other two strains (rom2Δ 
and sak1Δ) do have defects in TORC1 repression (Figure 3E and 
Supplemental Figure S3), the defects are minor compared with 
those caused by the deletion of Snf1/AMPK—a gene we previously 
identified as regulating TORC1 activity in glucose starvation condi-
tions (Figure 3E) (Hughes Hallett et al., 2014). Thus, the major 
regulators of TORC1-body formation identified in this study act 
downstream of, and/or in parallel with, the canonical TORC1 regula-
tory circuit to control TORC1 agglomeration and lock TORC1 in an 
inactive state.
Activators of TORC1-body formation acting upstream 
and downstream of Gtr1/2
Activators of TORC1-body formation could act 1) at, or above, the 
level of EGOC to promote release from the Gtr1/2-dependent 
repression of TORC1-body formation or 2) at a subsequent step to 
drive TORC1 agglomeration. To distinguish between these possibili-
ties, we created a series of double mutant strains, each missing Gtr1 
and one of the 13 regulators of TORC1-body formation identified in 
the screen. We also made a strain missing Gtr1 and Npr2 and a strain 
missing Gtr1 and carrying glutamine to alanine mutations in both 
prion-like domains of Kog1 (PrDm1+2) (Hughes Hallett et al., 2015) 
as controls for scenarios 1 and 2, respectively. All of these strains 
grew relatively well, except for bck1Δgtr1Δ (which we continued to 
study) and ypl150wΔgtr1Δ (which we dropped from the experiment), 
as described under Materials and Methods.
Measurement of TORC1-body formation in the double mutants 
revealed that the newly identified regulators fall into two distinct 
groups. Deletion of Gtr1 rescued the TORC1-body formation de-
fects found in the bck1Δ, slt2Δ, and rom2Δ strains (all proteins in the 
PKC pathway) (Levin, 2011), as well as the defects found in the 
gcn2Δ, pib2Δ, cka1Δ, npr2Δ, and sit4Δ strains (Figure 4). In contrast, 
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FIGURE 3: Screen for regulators of TORC1-body formation. (A) Histogram summarizing the 
influence that deleting 209 different genes (including all 139 nonessential kinases and 
phosphatases in yeast) has on Kog1-YFP foci formation. The score for each strain is based on 
the percentage of cells that form foci after 60 min of glucose starvation (based on data from at 
least 100 cells) and is normalized using wild-type data to calculate fold change. The raw data for 
each strain are included in Supplemental Table S1. (B) Heat map showing time-course data for 
the 45 strains that formed the fewest bodies in the initial screen (green/blue gene names), the 
13 strains that formed the most bodies in the initial screen (red gene names), and the wild-type 
strain (wt), in glucose and nitrogen starvation conditions. Each colored square shows the fraction 
of cells with Kog1-puncta at a particular time point, based on images of at least 100 cells. 
(C) Time-course data for the 13 strains with the largest defects in body formation (green 
and blue lines; gene names shown in bold in B), and the wild-type strain (black line). 
(D, E) Quantification of band-shift data measuring Sch9 phosphorylation during glucose 
starvation in strains missing key regulators of TORC1-body formation. The data were 
normalized so that the level of Sch9 phosphorylation in the wild-type strain at time zero is 
set at 1.0. The raw bandshift data for each strain are shown in Supplemental Figure S3.
deletion of Gtr1 had very little impact on 
TORC1-body formation in the ypk1Δ, 
cmk1Δ, sak1Δ, tco89Δ, yak1Δ, and prDm1+2 
strains (Figure 4). Thus, 7/13 genes we iden-
tified in the screen work together with Npr2 
to promote release from the Gtr1/2-depen-
dent repression of TORC1-body formation, 
while the remaining genes, including the in-
trinsically disordered TORC1 subunit Tco89, 
drive the subsequent steps in TORC1 ag-
glomeration along with the prionlike do-
mains in Kog1.
Remarkably, most (six of seven) of the 
proteins that act on, or at the level of, Gtr1 
to promote TORC1-body formation are re-
pressed by, or in a pathway that is repressed 
by, TORC1, including the following: Sit4, a 
type 2A–related phosphatase repressed by 
TORC1 via Tap42, involved in regulating a 
wide range of processes, including cell- 
cycle regulation (Di Como and Arndt, 1996; 
Jacinto et al., 2001; Loewith and Hall, 2011); 
Slt2/Mpk1, a MAPK in the PKC pathway re-
pressed by TORC1 and involved in the reg-
ulation of cell-wall integrity, cell-cycle pro-
gression, and proteasome activity (Krause 
and Gray, 2002; Torres et al., 2002; Moreno-
Torres et al., 2015; Rousseau and Bertolotti, 
2016); Rom2, an upstream activator in the 
PKC pathway (Ozaki et al., 1996; Levin, 
2011); Bck1, a MAPKKK in the PKC pathway 
that interacts with TORC1 (Breitkreutz et al., 
2010; Levin, 2011); Cka1, the alpha catalytic 
subunit of casein kinase 2 (CK2), recently 
found to be repressed by TORC1 and in-
volved in regulating RNA Pol III activity and 
other proteins/pathways (Sanchez-
Casalongue et al., 2015; Shekhar-Guturja et 
al., 2016); and Gcn2, a kinase repressed by 
TORC1 that has also been reported to act 
upstream of TORC1, involved in regulating 
amino acid biosynthesis (Cherkasova and 
Hinnebusch, 2003; Yuan et al., 2017).
These connections suggest that the inhi-
bition of TORC1 signaling in starvation con-
ditions helps drive the release of TORC1 
from the EGOC-dependent repression of 
TORC1-body formation via feedback. This 
probably helps to ensure that all of the 
TORC1 molecules in a cell are primed to 
move into bodies during long-term 
starvation.
However, TORC1-body formation is also 
controlled by an additional group of pro-
teins (Yak1, Ypk1, Cmk1, and Sak1) that ac-
tivate TORC1-body formation once TORC1 
is released from the EGOC-dependent re-
pression of TORC1 agglomeration. With 
the exception of Yak1 (Martin et al., 2004), 
these proteins are not linked to the TORC1/
EGOC signaling pathway and, instead, 
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FIGURE 4: Cooperation between Gtr1 and key regulators of 
TORC1-body formation. Impact that deleting key regulators of 
TORC1-body formation, or mutating the prion domains in Kog1 
(PrDm1+2), has on Kog1-YFP puncta formation in a gtr1Δ background. 
Black circles show the percentage of cells with bodies in log growth 
cultures, while black squares show the percentage of cells with bodies 
after 60 min of glucose starvation. The values shown are the average 
from experiments carried out on at least two different days with >100 
cells per time point, per replicate. The SD is <5% for all mutants and 
time points except for sak1Δ (60 min), gcn2Δ (60 min),  pib2Δ (60 min), 
cka1Δ (0 min), and sit4Δ (0 min), which have standard deviations of 
5–10%; npr2Δ (0 min),  sit4Δ (0 min), and sit4Δ (60 min), which have 
standard deviations of 10–15%; and slt2Δ (60 min) and npr2Δ (60 min), 
which have standard deviations of 15–20%. The red circle and square 
on the x-axis shows the data for the gtr1Δ single mutant for 
comparison.
FIGURE 5: Impact of Pib2 domains on TORC1-body formation. 
(A) Map of the different domains in Pib2 (as described in the text), 
and the structure of the Pib2 truncation mutants we constructed. The 
black lines in the ΔKBD and ΔFYVE mutants show that the 
neighboring domains are connected and do not represent 
polypeptide. (B) Time-course data following Kog1-YFP localization in 
strains carrying truncated forms of Pib2 at the Pib2 locus. Each time 
point shows the average and SD from experiments carried out on two 
different days, with 70–200 cells per time point per replicate (except 
t = 0, ΔNID+CAD, which had >40 cells per replicate). The solid lines 
show the best fit to a single exponential for the ΔNID, ΔNID+KBD, 
ΔCAD, and ΔNID+CAD strains and a straight line for the ΔKBD and 
ΔFYVE strains. The broken line shows the best fit to the wild-type 
data (from Figure 2) for comparison. Overexpression of Pib2 had little 
impact on TORC1-body formation; see Supplemental Figure S6 and 
Supplemental Text for details.
respond to membrane stress as part of the TORC2-Ypk1 pathway 
(Ypk1) (Roelants et al., 2011; Muir et al., 2014), calcium signals 
(Cmk1) (Cyert, 2001), and glucose/energy starvation (Sak1) (Elbing 
et al., 2006; Hedbacker and Carlson, 2008). It therefore appears 
that the second layer of regulation helps to ensure that multiple 
stress/starvation pathways are activated before a cell commits to 
the starvation state by forming TORC1-bodies.
Cooperation between Pib2 and EGOC
One of the most interesting findings from the double mutant analy-
sis is that Pib2—a protein that is required for TORC1-body forma-
tion in wild-type cells (Figure 3) and known to interact with both 
EGOC and TORC1 (Tarassov et al., 2008; Kim and Cunningham, 
2015; Michel et al., 2017)—becomes dispensable for TORC1-body 
formation in the absence of Gtr1 (Figure 4). But how? One possibil-
ity is that Pib2 is required for the starvation-dependent inactivation 
of Gtr1 and thus release of the Gtr1/2-dependent repression of 
TORC1-body formation, like Npr2. However, full-length Pib2 has 
been shown to activate TORC1 kinase activity (Kim and Cunning-
ham, 2015; Michel et al., 2017; Tanigawa and Maeda, 2017; Var-
lakhanova et al., 2017), while Npr2 represses TORC1 kinase activity 
(Neklesa and Davis, 2009; Panchaud et al., 2013)—indicating that 
Pib2 drives TORC1-body formation via a different mechanism than 
Npr2. Therefore, to learn more about the role that Pib2 plays in 
TORC1-body formation, we examined the impact that each domain 
in Pib2 has on Kog1-YFP localization.
Previous studies have shown that Pib2 contains four distinct do-
mains (Kim and Cunningham, 2015; Michel et al., 2017): 1) an N-
terminal domain that inhibits TORC1 activity; 2) a central domain 
that binds to Kog1; 3) a FYVE domain that binds to PI(3)P and recruits 
Pib2 to the vacuolar membrane; and 4) a C-terminal domain, includ-
ing a critical (and highly conserved) 15-amino-acid stretch from 
amino acids 620 to 635, that activates TORC1 (Figure 5A; see Sup-
plemental Text and Supplemental Figures S4–S6 for further details).
Deletion of the N-terminal inactivation domain (NID) of Pib2 in-
creased the fraction of cells that form TORC1-bodies in nutrient- 
replete conditions (from 8 ± 5% to 21 ± 1%) and on the 1-h timescale 
(from 56 ± 1% to 80 ± 2%)—indicating that this region of Pib2 inhib-
its TORC1-body formation (Figure 5B). In contrast, deletion of the 
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FIGURE 6: Pib2, EGOC, and TORC1 interact in log growth and starvation conditions. 
(A) Localization of GFP-Pib2 and Kog1-DuDre during log growth (left panels) and after 60 min of 
glucose starvation (right panels). The dashed lines show the position of each cell in the bright-
field image. (B) Coimmunoprecipitation experiments following interactions between Gtr1 and 
Kog1 (top panel) and Pib2 and Kog1 (bottom panel) before (0 min) and after 2 and 4 h of 
glucose starvation. The right-hand side of each blot shows the data for a mock IP (IP from cells 
missing the epitope tag on Kog1 or Pib2) used to measure the background levels of Gtr1 and 
Kog1 in the precipitate.
C-terminal activating domain (CAD), Kog1-binding domain (KBD), 
and FYVE domain (FYVE) slowed or blocked TORC1-body forma-
tion, indicating that these domains promote TORC1-body forma-
tion (Figure 5B).
The data showing that the Kog1-binding domain in Pib2 is re-
quired for TORC1-body formation are especially interesting since pre-
vious studies have shown that this domain is dispensable for TORC1 
activity (in SD medium). Moreover, they suggest that Pib2 drives 
TORC1-body formation via a direct interaction with Kog1/TORC1.
To test this idea, we created a strain carrying Pib2 tagged with 
green fluorescent protein (GFP-Pib2) and Kog1-DuDre and followed 
their localization during glucose starvation. This experiment revealed 
that 1) Pib2 is located on both the vacuolar membrane, and foci as-
sociated with the membrane, in nutrient-replete medium—just like 
EGOC—and 2) that Kog1 and Pib2 both reside in the TORC1-body 
(also occupied by EGOC) during starvation (93% overlap, n = 128 
cells with Kog1 foci; Figure 6A). We also performed coimmunopre-
cipitation experiments (after cross-linking) to see whether Pib2, 
EGOC, and TORC1 bind to each other during log growth (when 
TORC1 is distributed across the vacuolar membrane) and/or in star-
vation conditions (when TORC1 is in a body). These experiments 
showed that Pib2 and Kog1, and Gtr1 and Kog1, interact at similar 
levels in both nutrient replete and starvation conditions (Figure 6B).
Thus, Pib2, EGOC, and TORC1 form a complex that blocks 
TORC1-body formation when EGOC is active (in nutrient-replete 
conditions) but permits TORC1 to form bodies when EGOC is inac-
tive (during starvation). In this complex, EGOC constantly acts to 
inhibit TORC1-body formation, likely via direct binding to TORC1. 
However, when Gtr1/2 are in the inactive state, Pib2 overwhelms the 
repressive effect of EGOC so that TORC1-bodies can form.
DISCUSSION
Regulation of TORC1-body formation
In our original study of TORC1 localization (Hughes Hallett et al., 
2015), we followed the movement of Kog1-YFP, Tco89-YFP, and 
Tor1 with a triple GFP insertion (Sturgill et 
al., 2008) in different stress and starvation 
conditions. Those experiments showed 
that Kog1-YFP and Tco89-YFP move into a 
body during glucose and nitrogen starva-
tion (with a time constant of 10 min) while 
Tor1D330-3xGFP remains on the vacuolar mem-
brane/cytoplasm—leading us to conclude 
that TORC1 dissociates in starvation 
conditions so that Kog1 and Tco89 can 
move into a “Kog1 body.” However, recent 
experiments examining the localization of 
GFP-Tor1 have shown that Tor1 also moves 
into a body (Kira et al., 2016; Prouteau et 
al., 2017), indicating that the internal 3xGFP 
tag disrupts Tor1 localization. We have con-
firmed these results (unpublished data) and 
therefore refer to TORC1-bodies, rather 
than Kog1-bodies, throughout this article.
In the same study, we showed that 
AMPK/Snf1 phosphorylates Kog1 during 
glucose starvation at two novel sites (Ser 
491 and 494) and that these phosphoryla-
tion events help drive the formation of 
TORC1-bodies (TORC1-bodies form 20-
fold slower in Kog1S491/494A and snf1Δ cells). 
We also showed that two glutamine-rich, 
prion-like domains in Kog1 help drive TORC1-body formation 
(TORC1-bodies form >100-fold slower in the strongest prion mu-
tant; PrDm1+2). Then, by studying strains with mutations that limit 
TORC1-body formation (Kog1S491/494A, PrDm1+2, and others), we 
showed that TORC1-bodies are not required for the rapid inactiva-
tion of TORC1 but instead increase the threshold for TORC1 activa-
tion in cells that have been starved for a significant period of time 
(from around 0.02% glucose, to around 2% glucose). In other words, 
TORC1-body formation creates hysteresis (memory) in the TORC1 
pathway to help ensure that cells remain committed to a starvation 
state until they are exposed to optimal conditions. In line with this, 
cells carrying Asp or Glu mutations at Ser 491 and 494 in Kog1 
(phosphomimetics) fail to grow—even in rich medium.
Here, to build on our previous work, we set out to learn more 
about how TORC1-body formation is regulated and, in particular, 
whether/how the major TORC1 regulators Gtr1/2 (Rag A/B and 
C/D in humans) impact TORC1-body formation—with the goal of 
building an integrated model of TORC1 regulation in yeast.
Our new data show that TORC1-body formation and TORC1 in-
hibition are tightly coupled events. Specifically, we show that glu-
cose and nitrogen starvation both trigger inhibition of the Gtr1/2 
complex (i.e., a switch from the GTP/GDP to the GDP/GTP-bound 
state). This signaling event is well known to help drive inhibition of 
TORC1 kinase activity (Binda et al., 2009; Nicastro et al., 2017): In 
the case of nitrogen starvation, Gtr1/2 inhibition is responsible for 
∼50% of the rapid and complete repression of TORC1 activity 
(Hughes Hallett et al., 2014). In the case of glucose starvation, 
Gtr1/2 inhibition is responsible for only ∼20% of the rapid and com-
plete repression of TORC1 activity, since Snf1/AMPK and other un-
known pathways play a dominant role in the response (Hughes Hal-
lett et al., 2014). At the same time, Gtr1/2 inhibition also allows 
TORC1 to form bodies. Importantly, however, it is not TORC1 inhibi-
tion itself that promotes TORC1-body formation, since TORC1 is 
fully repressed in numerous mutant strains that have dramatic de-
fects in TORC1-body formation (some of which can be rescued by 
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FIGURE 7: Working model of TORC1 regulation. See the text for 
details.
deletion of Gtr1). Instead, it appears that Gtr1/2 has a dual role: 1) 
helping control TORC1 activity, particularly in response to nitrogen 
and amino acid signals, and 2) acting as a glucose and nitrogen 
starvation-dependent gate for TORC1-body formation. This dual 
role ensures that starvation signals are sent through the Gtr1/2—at 
least partially inactivating TORC1—before TORC1 can agglomerate 
and lock the pathway in a hyperrepressed state.
Our data also point to a second mechanism coupling TORC1 
inhibition to TORC1-body formation: most (six of seven) of the 
proteins that are required for the release from Gtr1/2-dependent 
repression of TORC1-body formation are repressed by, or are in a 
pathway that is repressed by, TORC1 itself. It therefore appears that 
TORC1 inhibition promotes TORC1-body formation by activating 
several feedback loops.
While TORC1-body formation is tightly coupled to TORC1 inhibi-
tion via Gtr1/2 and feedback, it is important to note that the late 
steps in TORC1-body formation (those that occur after the release 
from the Gtr1/2-dependent repression of body formation) depend 
on stress and starvation signaling proteins that are not directly linked 
to the TORC1 pathway (Sak1, Ypk1, and Cmk1). Further work is 
needed to pick apart the influence that of these proteins have on 
TORC1 signaling, but it seems likely that they help limit TORC1-body 
formation until multiple stress/starvation pathways are activated.
Our data also provide important insight into the mechanism un-
derlying the Gtr1/2-dependent gating of TORC1-body formation. 
We show that Gtr1/2 inhibits TORC1-body formation in nutrient 
replete conditions (when it is active) but becomes dispensable for 
TORC1-body formation during starvation (when it is inactive). We 
also show that the inactivation of the Gtr1/2-dependent repression 
of TORC1-body formation requires Pib2—a protein that forms a 
complex with TORC1 in both log growth and starvation conditions. 
These results suggest that that the tight interaction between 
Gtr1/2 and TORC1 in nutrient-replete conditions pins TORC1 in a 
conformation that has a low propensity to agglomerate and/or 
covers a surface of TORC1 that is needed for body formation (e.g., 
the prion-like domains in Kog1; Figure 7). Then, when the interac-
tion between Gtr1/2 and TORC1 is weakened in starvation condi-
tions (by a switch to the inactive GDP/GTP bound form of Gtr1/2), 
Pib2 pulls TORC1 into a new conformation that is primed to ag-
glomerate (Figure 7).
The discovery that Pib2 is required for the Gtr1/2-dependent 
regulation of TORC1-body formation builds on previous work show-
ing that Pib2 and Gtr1/2 work together to control TORC1 activation 
(Kim and Cunningham, 2015; Worley et al., 2015; Michel et al., 
2017; Tanigawa and Maeda, 2017; Varlakhanova et al., 2017). We 
therefore propose that EGOC and Pib2 act as a single complex ma-
chine—to control both Gtr1/2-dependent TORC1 activation and 
TORC1-body formation. In this context, it will be interesting to 
determine whether/how the related protein, LAPF/phafin-1, modu-
lates Rag GTPase function in humans.
Comparison between TORC1-bodies and TOROIDS
While we were completing this work, Prouteau et al. (2017) pub-
lished a new study of TORC1 localization. They report that TORC1 
moves rapidly into and out of foci on a timescale that matches Sch9 
phosphorylation and dephosphorylation (τ = 2 min). They also re-
port that active Gtr1/2 limits TORC1-body formation and that dele-
tion of Gtr1/2 leads to TORC1 agglomeration in 60% of cells, even 
in nutrient-replete medium—leading them to conclude that Gtr1/2 
are the dominant regulators of TORC1 agglomeration.
The differences between their results and our results may be 
due to different experimental setups, since Prouteau et al. (2017) 
examined TORC1 localization in cells that were transitioning in and 
out of stationary phase (adding and subtracting nutrients where ap-
propriate), while we followed TORC1 localization in cells that had 
been kept in log growth phase for >12 h. There may also be some 
strain-to-strain differences in the exact rates and levels of TORC1-
body formation.
Prouteau et al. (2017) also analyzed the structure of TORC1 puri-
fied from cells in stationary phase using CryoEM. Their analysis shows 
that TORC1 molecules can pack in a helical array to form a hollow 
tube with a length of up to 1 μM. This packing occludes the active site 
of the complex. Using STORM microscopy, the authors then confirm 
that some (<20%) of the TORC1 agglomerates formed in vivo are 
elongated. To test the impact that these TORC1 fibers (called TO-
ROIDS) have on TORC1 activity, Prouteau et al. then introduced the 
same Tor1D330-3XGFP construct that we used in our original study (and 
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found does not move to bodies), arguing that the 3xGFP is in an ideal 
position to disrupt TOROID assembly. They find that Sch9 is phos-
phorylated at a high level in the Tor1D330-3XGFP strain, even during glu-
cose starvation—leading them to conclude that TOROID formation is 
required for TORC1 inactivation in glucose starvation conditions.
The argument that TORC1 agglomeration is required for rapid 
TORC1 inactivation is incompatible with our data, showing that 14 
different strains with major defects in TORC1-body formation all 
turn off TORC1 signaling normally (or nearly normally) in glucose-
starvation conditions (GTR1Q65L and the 13 mutants identified in the 
screen; Figure 3 and Supplemental Figure S3). Instead, we believe 
there are two possible explanations for the TORC1 signaling defect 
found in the Tor1D330-3XGFP strain. The first is simply that the insertion 
of three GFPs into Tor1 blocks the access of a key regulatory protein 
to TORC1. The second is that interactions between individual 
TORC1 molecules (like those found in the TOROID) do help inacti-
vate TORC1 in starvation conditions (leading to the signaling defect 
in the Tor1D330-3XGFP strain), but the assembly into a higher-order 
agglomerate—visible in the microscope and disrupted in our mu-
tants—is only required to stabilize the off state of TORC1. A model 
of this type could also help resolve additional conflicts between our 
data and the data of Prouteau et al. (2017), namely, 1) that the 
TOROID structure does not include Tco89 (a key driver of TORC1 
agglomeration) or explain why the prion-like domains in Kog1 help 
drive TORC1 agglomeration and 2) that in our microscopy experi-
ments, we never see the kind of highly elongated fibers found in the 
structural studies of Prouteau et al. (2017) Therefore, it may be that 
the individual TORC1–TORC1 interactions identified in the CryoEM 
structure form in vivo, but the interactions formed with, and 
between, Tco89, the prion domains in Kog1, Pib2, and EGOC pull 
small TORC1 agglomerates into globular bodies and block the 
formation of the long fibers seen in vitro.
Further experiments are needed to resolve these issues and inte-
grate the exciting findings of Prouteau et al. (2017) with our data 
and two-step model of TORC1 regulation (rapid TORC1 inhibition 
followed by TORC1-body formation; Figure 7). However, from the 
work completed to date, it is clear that the movement of TORC1 
into and out of higher-order structures is a carefully controlled 
process that plays an important role in regulating TORC1 activity. 
Moving forward, it will therefore be interesting to determine 
precisely how TORC1-body formation tunes signaling through 




Most of the strains used in this study were generated in a haploid 
S. cerevisiae strain, W303 background (trp1, can1, leu2, his3, ura3), 
using standard methods. The exceptions were as follows: 1) To 
make the strain carrying a Gtr1Q65L allele at the native Gtr1 locus, we 
first knocked out GTR1 using the pCORE cassette, containing both 
a URA3 and Kan markers (Storici and Resnick, 2006). We then cloned 
the mutant form of GTR1 from a plasmid provided from the De 
Virgilio lab and introduced it into the gtr1Δ cell line. Finally, we se-
lected for cells that had integrated the mutant GTR1 at the native 
locus via selection with 5FOA and by searching for colonies that die 
on kanamycin (G418) plates. 2) We also used the pCORE cassette to 
build the strains carrying truncated forms of Pib2 at the native locus. 
PCR was used to create truncated versions of the Pib2 gene, and the 
fragments were integrated at the native Pib2 locus by transforming 
them into strains that had the entire Pib2, or part of the Pib2 gene, 
replaced with the pCORE cassette. 3) GFP-Pib2 was created by 
cloning the tagged gene from a plasmid provided by the Cunning-
ham lab and integrating it at the native locus—as described above 
for the truncation mutants. In cases 1–3, the integrity of the final 
gene product was confirmed by sequencing the Pib2 or Gtr1 gene 
and surrounding regions. 4) Strains carrying Kog1-DuDre and Ego1-
YFP or Gtr1-YFP and the strains carrying Kog1-YFP and Ego1/Ego3/
Gtr1-DuDre were made by mating and tetrad dissection.
The double mutant strains examined in Figure 4 were made by 
knocking each of the relevant Kog1-body regulators out in the 
gtr1Δ strain. In all but two cases (ypl150wΔ gtr1Δ and bck1Δgtr1Δ) 
the transformation led to a standard number of positive colonies 
and the resulting strain grew at a rate similar to that of the gtr1Δ 
parental strain. However, since previous reports indicated that the 
gtr1Δpib2Δ strain is inviable (Kim and Cunningham, 2015), we 
checked that we had not made a mistake by building it several 
times. In all cases, we identified a standard number of colonies and 
the strains grew at approximately the same rate as the gtr1Δ strain.
All strains used in this study are listed in Supplemental Table S2.
Fluorescence microscopy
Cells were taken from a fresh yeast extract peptone dextrose (YEPD) 
plate and grown for 5–6 h in SD medium in a 35-ml test tube on a 
rotator at 30°C, until they reached an OD600 of ∼0.1. The starter 
cultures were then used to inoculate 20 ml of SD medium in a 
125-ml conical flask to an OD600 of ∼0.001 and allowed to grow 
shaking at 200 rpm and 30°C, until they reached mid–log phase. At 
this point, 400-μl samples were transferred to a chamber slide (Ibidi 
μ-slide, eight-well; 80827) that had been treated with 2 mg/ml con-
canavilin A and examined on the microscope. The slides were then 
washed three times with 400 μl starvation medium (either SD minus 
glucose or SD minus nitrogen [no amino acids or ammonium sulfate]) 
and loaded into a 30°C chamber on the microscope, and protein 
localization was followed over time.
Images were acquired using a DeltaVision Elite Microscope 
equipped with an Olympus 100×, 1.4NA, objective and a scientific 
complementary metal–oxide–semiconductor (sCMOS) camera. We 
collected a Z-series of 16 images with 0.4-μm spacing in the YFP 
(YFP filter; Ex. 496–528 nm, Em. 537–559 nm), GFP (GFP filter; Ex. 
425–495 nm, Em. 500–550 nm), and/or RFP (RFP filter; Ex. 555–590 
nm, Em. 600–675 nm) channels at each time point to ensure that all 
of the fluorescent foci in the cell were detected. Image files were 
then processed in ImageJ (Schneider et al., 2012) to create the max-
imum projection from the stack.
We calculated the fraction of cells containing one or more 
TORC1-bodies using a custom pipeline in CellProfiler (Carpenter 
et al., 2006). In all cases, the results were checked by manual inspec-
tion and adjusted if necessary. Where appropriate time-course data 
were fitted to a single exponential equation, A*(1-e-t/τ) + c, or dou-
ble exponential equation, A1*(1-e-t/τ1) + A2*(1-e-t/τ2) + c, where A (or 
A1 + A2) is the fraction of cells that form bodies during the time 
course, τ is the apparent time constant, and c is the fraction of cells 
that have bodies at the start of the time course. In cases where there 
was no change in TORC1-body levels during the time course, the 
data were fitted to a line. All fitting was done in Igor Pro 6.3 (Wave-
Metrics), and the errors reported are the SD estimated from the fit.
Sch9 bandshift experiments
Bandshift measurements were performed as described previously 
(Urban et al., 2007; Hughes Hallett et al., 2014, 2015), except that 
the data were quantified using Image Studio software (LiCor) by 
comparing the total intensity of the upper (phosphorylated) bands 
to the total intensity of the upper and lower (phosphorylated and 
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dephosphorylated) bands at each time point (to calculate the fraction 
Sch9 phosphorylated). The values for all time points and strains were 
then multiplied by a single constant so that the fraction of Sch9 
phosphorylated at time zero in the wild-type strain is set to 1.0.
Coimmunoprecipitation experiments
Cells were grown in 750 ml of SD medium, shaking at 200 rpm and 
30°C, until they reached mid–log phase (OD600 between 0.55 and 
0.6). At that point, one-third of the culture was harvested by filtra-
tion and flash frozen. Approximately 1 min later, the other two-thirds 
of the culture was collected on a separate filter, washed with SD 
medium missing glucose, and added to a flask containing 500 ml of 
SD medium missing glucose and grown for an additional 2 or 4 h 
before it was collected using filtration.
Immunopurifications were performed using a modified version 
of the protocol by Murley and Nunnari (Murley et al., 2017) designed 
to identify protein–protein interactions on membranes. Cells were 
resuspended in 4 ml of lysis buffer (20 mM HEPES, 150 mM potas-
sium acetate, 2 mM magnesium acetate, 1 mM ethylene glycol-
bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid [EGTA], and 
0.6 M sorbitol at pH 7.4) containing Roche complete protease and 
phosphatase inhibitors and lysed by bead beating (6 × 1 min). The 
lysates were then cleared by centrifugation at 3000 rpm for 5 min on 
a benchtop centrifuge and treated with 1 mM dithiobis succinimidyl 
propionate (a reversible cross-linker; Thermo Fisher Scientific) for 
30 min at 4°C. The reaction was then quenched by the addition of 
100 mM Tris–HCl (pH 7.5) to the sample and incubation on ice for 
30 min. Membranes were then solubilized by the addition of 1% 
digitonin (Cayman) and nutation at 50 rpm and 4°C for 60 min, and 
the lysates cleared by centrifugation at 12,000 × g for 10 min at 4°C.
In the GFP-Pib2 purifications, the clarified lysates were incu-
bated with 50 μl of μMACs monoclonal mouse anti-GFP magnetic 
microbeads (Miltenyi Biotec) at 4°C for 30 min. μMAC columns were 
then equilibrated in the lysis buffer +1% digitonin and protease 
inhibitors; loaded with the beads; washed three times with 800 μl 
lysis buffer, 0.1% digitonin, and Roche protease inhibitors; and then 
washed two times with 800 μl lysis buffer. The proteins were then 
eluted in 50 mM Tris–HCl (pH 6.8), 50 mM dithiothreitol, 1% SDS, 
1 mM EDTA at 95°C.
In the Kog1-FLAG purifications, the clarified lysates were incu-
bated with 10 μg of anti-FLAG M2 antibody (Sigma) for 3 h, and 
then Protein A/G Ultralink resin (Pierce) for an additional 2 h, all at 
4°C with slow rotation. The resin was then washed three times with 
800 μl lysis buffer, 0.1% digitonin, and Roche protease inhibitors, 
and two times with 800 μl lysis buffer, before the resin was boiled in 
SDS–PAGE loading buffer to elute Kog1 and associated proteins.
The protein samples from each experiment (three time points for 
each IP and the matching controls) were run on a single 8% SDS–
PAGE gel and transferred to a nitrocellulose membrane using stan-
dard procedures. The membrane was then cut in half to separate 
the higher- and lower-molecular-weight regions (using a prestained 
ladder as a guide). The high-molecular-weight portion of the mem-
brane was then incubated with anti-FLAG antibody (M2; Sigma) to 
detect Kog1-FLAG, while the lower weight portion of the mem-
brane was incubated with anti-GFP to detect GFP-Pib2 (4B10B2; 
Roche) or anti-myc (9E10; Roche) to detect Gtr1-myc.
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